Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster
Bristol Myers Squibb’s deucravacitinib flunks midphase IBD trial, raising questions [...]
Denali makes ALS play, hustling Sanofi-partnered drug into phase 2 and sharing early data on internal program
Denali makes ALS play, hustling Sanofi-partnered drug into phase 2 [...]
Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future of neuroscience R&D
Meet Neumora, Arch’s $500M, Amgen-partnered play for the targeted future [...]
Dengue compound backed by J&J shows potency against the virus and all known variants in mice
Dengue compound backed by J&J shows potency against the virus [...]
EQRx’s affordable drug drive leads to Absci discovery pact
EQRx’s affordable drug drive leads to Absci discovery pact ntaylor [...]
Voyager Therapeutics looks to shake off a tough year as it pens Pfizer gene therapy pact worth $630M
Voyager Therapeutics looks to shake off a tough year as [...]
Gemini axes CSO and 20% of staff to focus on late-phase plans
Gemini axes CSO and 20% of staff to focus on [...]
Collins, after 12 years at the NIH helm, will exit by year-end
Collins, after 12 years at the NIH helm, will exit [...]
AstraZeneca files for FDA green light of COVID-preventing antibody
AstraZeneca files for FDA green light of COVID-preventing antibody ntaylor [...]
New insights into the ‘second brain’ in the gut could inspire treatments for intestinal diseases MSU team reports
New insights into the ‘second brain’ in the gut could [...]